Pablo Corral on Why Early LDL-C Reduction Saves Lives
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared on LinkedIn:
”Statins:
- The Power of Early Intervention and the Reality of the Legacy Effect
- The long arc of cardiovascular prevention continues to point in one direction: earlier LDL-C reduction delivers deeper, long-lasting protection. Two landmark analyses reinforce this principle with remarkable clarity.
The Scandinavian Simvastatin Survival Study (4S)—now revisited three decades after its publication—established that intensive LDL-C lowering not only reduces cardiovascular events but fundamentally alters long-term disease trajectories.
Its impact initiated a paradigm shift in dyslipidaemia management that persists today. (10.1016/S0140-6736(24)02089-0)
The ASCOT-Legacy 20-year follow-up extends this insight even further.
Despite convergence of lipid levels after trial completion, participants originally randomised to atorvastatin maintained significant long-term reductions in non-fatal myocardial infarction, fatal coronary heart disease, total coronary events, and cardiovascular mortality—demonstrating a true “legacy effect.”
Each 1 mmol/L lower in-trial LDL-C was associated with substantial long-term reductions in cardiovascular and all-cause mortality. (10.1136/heartjnl-2024-325104)
Key message:
- Statins do more than lower LDL-C today—they reduce the cumulative cholesterol burden that determines tomorrow’s risk.
- Starting earlier, treating consistently, and achieving lower LDL-C levels is not aggressive medicine—it is simply good medicine.
As the evidence mounts, the clinical imperative becomes harder to ignore:
Delay is costly.
Early, sustained lipid-lowering therapy saves lives.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology